Anavex Life Sciences Corp (AVXL)

[BakedLangostino]

I agree. His credibility is officially shot. This is a huge blow to the WGT crowd, because while I believe he was telling the truth that there was some sort of inconsequential safety issue that delayed the Rett data, I also believe he knew more than he was leading on or at least had his suspicions. Then again, it's possible he was just as blindsided as we were when he received the official data within the past 4 days or however long he has to disclose material information.

Worst case: Anavex submits for FDA approval on a skinny-label type of indication, one for adults only. There's some value there and I guess as is many things in America, the rich families with Rett children can ask their pediatricians to off-label Rx it and just pay the $500k or whatever it costs out of pocket. Sales in Europe could potentially be stronger because of the single-payer system.

But the real pearl is Alzheimer's data. Either Dr. Missling is full of crap or he's not. A shareholder demand that he answer unequivocally whether Alzheimer's data has been submitted to a journal as of today is necessary. If it has, let's see how it plays out. If not, all his recent PRs about upcoming peer-review is a crock and nothing he says can be trusted. An easy litmus test, and every shareholder should be writing letters to IR or Dr. Missling personally (I think his email is [e-mail] but I could be mistaken -- worst case give it a try and see if it bounces). Rett can pressure the FDA based on RWE and shareholders should be pressuring Dr. Missling to clearly communicate whether any journals have received full Alzheimer's data to review and publish?